Ekachai Medical Care PCL (BKK:EKH)

Market Cap	3.95B -20.1%
Revenue (ttm)	1.25B -2.8%
Net Income	257.93M -9.5%
EPS	0.32 -10.5%
Shares Out	800.00M
PE Ratio	15.42
Forward PE	15.95
Dividend	0.30 (6.07%)
Ex-Dividend Date	May 5, 2026

Volume	229,031
Open	4.960
Previous Close	4.960
Day's Range	4.940 - 4.960
52-Week Range	4.900 - 6.000
Beta	-0.01
Analysts	Hold
Price Target	5.08 (+2.83%)
Earnings Date	Aug 7, 2026

About Ekachai Medical Care PCL

Ekachai Medical Care Public Company Limited, together with its subsidiaries, operates Ekachai hospital in Thailand. The company offers various surgeries comprising face and neck lift; forehead augmentation; eyelid and ear correction; nose reshaping; breast lifting, implants, reduction with implants, and lifting without implants; nipple-areolar; preventive mastectomy; male breast reduction; mastectomy; power assisted and body tite liposuction; lipofilling; body contouring; female genetical cosmetic; and gender reassugnment. It also operates cosm...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2003
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: EKH

Financial Performance

In 2025, Ekachai Medical Care PCL's revenue was 1.24 billion, a decrease of -5.15% compared to the previous year's 1.31 billion. Earnings were 262.30 million, a decrease of -6.34%.

Analyst Summary

According to 3 analysts, the average rating for EKH stock is "Hold." The 12-month stock price target is ฿5.08, which is an increase of 2.83% from the latest price.

Price Target

฿5.08

(2.83% upside)

Analyst Consensus: Hold